Table of Content




1. Introduction
1.1. Report Description

2. Executive Summary
2.1. Key Highlights

3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities

4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2016-2027)
4.1.2. Canada Market Status and Outlook (2016-2027)
4.1.3. Mexico Market Status and Outlook (2016-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2016-2027)
4.2.2. France Market Status and Outlook (2016-2027)
4.2.3. UK Market Status and Outlook (2016-2027)
4.2.4. Russia Market Status and Outlook (2016-2027)
4.2.5. Italy Market Status and Outlook (2016-2027)
4.2.6. Rest of Europe Market Status and Outlook (2016-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2016-2027)
4.3.2. Japan Market Status and Outlook (2016-2027)
4.3.3. Korea Market Status and Outlook (2016-2027)
4.3.4. India Market Status and Outlook (2016-2027)
4.3.5. Southeast Asia Market Status and Outlook (2016-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2016-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2016-2027)
4.4.2. Argentina Market Status and Outlook (2016-2027)
4.4.3. Columbia Market Status and Outlook (2016-2027)
4.4.4. Rest of South America Market Status and Outlook (2016-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2016-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2016-2027)
4.5.3. Egypt Market Status and Outlook (2016-2027)
4.5.4. Nigeria Market Status and Outlook (2016-2027)
4.5.5. South Africa Market Status and Outlook (2016-2027)
4.5.6. Turkey Market Status and Outlook (2016-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5. Pets Anti-infectives Market, By Type
5.1. Introduction
5.2. Global Pets Anti-infectives Revenue and Market Share by Type (2016-2019)
5.2.1. Global Pets Anti-infectives Revenue and Revenue Share by Type (2016-2019)
5.3. Antibacterial
5.3.1. Global Antibacterial Revenue and Growth Rate (2016-2019)
5.4. Antivirals
5.4.1. Global Antivirals Revenue and Growth Rate (2016-2019)
5.5. Antifungals
5.5.1. Global Antifungals Revenue and Growth Rate (2016-2019)
5.6. Others
5.6.1. Global Others Revenue and Growth Rate (2016-2019)

6. Pets Anti-infectives Market, By Applications
6.1. Introduction
6.2. Global Pets Anti-infectives Revenue and Market Share by Applications (2016-2019)
6.2.1. Global Pets Anti-infectives Revenue and Revenue Share by Applications (2016-2019)
6.3. Dogs
6.3.1. Global Dogs Revenue and Growth Rate (2016-2019)
6.4. Cats
6.4.1. Global Cats Revenue and Growth Rate (2016-2019)
6.5. Other
6.5.1. Global Other Revenue and Growth Rate (2016-2019)

7. Pets Anti-infectives Market, By Region
7.1. Introduction
7.2. Global Pets Anti-infectives Revenue and Market Share by Regions
7.2.1. Global Pets Anti-infectives Revenue by Regions (2016-2019)
7.3. North America Pets Anti-infectives by Countries
7.3.1. North America Pets Anti-infectives Revenue and Growth Rate (2016-2019)
7.3.2. North America Pets Anti-infectives Revenue (Million USD) by Countries (2016-2019)
7.3.3. United States
7.3.3.1. United States Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.3.4. Canada
7.3.4.1. Canada Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.3.5. Mexico
7.3.5.1. Mexico Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4. Europe Pets Anti-infectives by Countries
7.4.1. Europe Pets Anti-infectives Revenue and Growth Rate (2016-2019)
7.4.2. Europe Pets Anti-infectives Revenue (Million USD) by Countries (2016-2019)
7.4.3. Germany
7.4.3.1. Germany Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4.4. France
7.4.4.1. France Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4.5. UK
7.4.5.1. UK Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4.6. Russia
7.4.6.1. Russia Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4.7. Italy
7.4.7.1. Italy Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5. Asia-Pacific Pets Anti-infectives by Countries
7.5.1. Asia-Pacific Pets Anti-infectives Revenue and Growth Rate (2016-2019)
7.5.2. Asia-Pacific Pets Anti-infectives Revenue (Million USD) by Countries (2016-2019)
7.5.3. China
7.5.3.1. China Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5.4. Japan
7.5.4.1. Japan Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5.5. Korea
7.5.5.1. Korea Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5.6. India
7.5.6.1. India Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.6. South America Pets Anti-infectives by Countries
7.6.1. South America Pets Anti-infectives Revenue and Growth Rate (2016-2019)
7.6.2. South America Pets Anti-infectives Revenue (Million USD) by Countries (2016-2019)
7.6.3. Brazil
7.6.3.1. Brazil Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.6.4. Argentina
7.6.4.1. Argentina Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.6.5. Columbia
7.6.5.1. Columbia Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7. Middle East and Africa Pets Anti-infectives by Countries
7.7.1. Middle East and Africa Pets Anti-infectives Revenue and Growth Rate (2016-2019)
7.7.2. Middle East and Africa Pets Anti-infectives Revenue (Million USD) by Countries (2016-2019)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.5. Egypt
7.7.5.1. Egypt Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.6. Nigeria
7.7.6.1. Nigeria Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.7. South Africa
7.7.7.1. South Africa Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.8. Turkey
7.7.8.1. Turkey Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2016-2019)
8. Company Profiles
8.1. Boehringer Ingelheim
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Zoetis
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Merck
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Elanco
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bayer
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Virbac
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Ceva Sante Animale
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Vetoquinol
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Bimeda Animal Health
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Chanelle
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview

9. Pets Anti-infectives Market Forecast (2019-2027)
9.1. Global Pets Anti-infectives Revenue (Millions USD) and Growth Rate (2019-2027)
9.2. Pets Anti-infectives Market Forecast by Regions (2019-2027)
9.2.1. North America Pets Anti-infectives Market Forecast (2019-2027)
9.2.1.1. United States Pets Anti-infectives Market Forecast (2019-2027)
9.2.1.2. Canada Pets Anti-infectives Market Forecast (2019-2027)
9.2.1.3. Mexico Pets Anti-infectives Market Forecast (2019-2027)
9.2.2. Europe Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.1. Germany Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.2. France Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.3. UK Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.4. Russia Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.5. Italy Pets Anti-infectives Market Forecast (2019-2027)
9.2.2.6. Rest of Europe Pets Anti-infectives Market Forecast (2019-2027)
9.2.3. Asia-Pacific Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.1. China Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.2. Japan Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.3. Korea Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.4. India Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.5. Southeast Asia Pets Anti-infectives Market Forecast (2019-2027)
9.2.3.6. Rest of Asia-Pacific Pets Anti-infectives Market Forecast (2019-2027)
9.2.4. South America Pets Anti-infectives Market Forecast (2019-2027)
9.2.4.1. Brazil Pets Anti-infectives Market Forecast (2019-2027)
9.2.4.2. Argentina Pets Anti-infectives Market Forecast (2019-2027)
9.2.4.3. Columbia Pets Anti-infectives Market Forecast (2019-2027)
9.2.4.4. Rest of South America Pets Anti-infectives Market Forecast (2019-2027)
9.2.5. Middle East and Africa Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.1. Saudi Arabia Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.2. United Arab Emirates Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.3. Egypt Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.4. Nigeria Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.5. South Africa Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.6. Turkey Pets Anti-infectives Market Forecast (2019-2027)
9.2.5.7. Rest of Middle East and Africa Pets Anti-infectives Market Forecast (2019-2027)
9.3. Pets Anti-infectives Market Forecast by Type (2019-2027)
9.3.1. Pets Anti-infectives Forecast by Type (2019-2027)
9.3.2. Pets Anti-infectives Market Share Forecast by Type (2019-2027)
9.4. Pets Anti-infectives Market Forecast by Applications (2019-2027)
9.4.1. Pets Anti-infectives Forecast by Applications (2019-2027)
9.4.2. Pets Anti-infectives Market Share Forecast by Applications (2019-2027)